Status:
COMPLETED
Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic
Lead Sponsor:
Istanbul University
Conditions:
Behcet Disease
COVID
Eligibility:
All Genders
18-65 years
Brief Summary
Behcet' disease (BD) is a chronic inflammatory disease which is characterized by oral and genital ulcers, uveitis and skin lesions. Musculoskeletal involvement such as arthrits, arthralgia, enthesis a...
Eligibility Criteria
Inclusion
- Being between the ages of 18-65
- Being diagnosed with FMF at least 1 year ago according to diagnostic criteria
- A diagnosis of BiH at least 1 year ago according to the International Behçet Working Group
- Having signed the informed consent form
- Having a cooperative level that will respond to evaluation scales
Exclusion
- Pregnant women
- Having other chronic diseases
- Psychiatric disorders and treated
- Those with cognitive impairment
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04403438
Start Date
April 1 2020
End Date
March 15 2021
Last Update
February 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IstanbulU
Istanbul, Bakırköy, Turkey (Türkiye), 34740